ZYME
Zymeworks·NASDAQ
--
--(--)
--
--(--)
6.07 / 10
Outperform
Analyst consensus is bullish: 50% Strong Buy, 50% Buy, weighted rating 4.39. Fund‑flow score 7.75/10 shows overall positive inflows except a slight negative trend in large blocks. Sentiment score 6.07 rates outperformance, supporting a favorable short‑term bias.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-03
InstitutionLeerink Partners
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for ZYME?
- ZYME holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.07/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
